Effect of recombinant human endostatin onradiotherapy for esophagus cancer.

Journal: Asian Pacific journal of tropical medicine
Published Date: Dec 19, 2015

Abstract

OBJECTIVE: To investigate the effect of radiotherapy plus recombinant human endostatin (RH-endostatin) on esophageal cancer and its mechanism.

Authors

  • Gao-Feng Liu
    Department of Thoracic Surgery, No. 153 Hospital of Liberation Army, Zhengzhou, China.
  • Hui Chang
    Department of Thoracic Surgery, No. 153 Hospital of Liberation Army, Zhengzhou, China.
  • Bao-Tian Li
    Department of Thoracic Surgery, No. 153 Hospital of Liberation Army, Zhengzhou, China.
  • Yong Zhang
    Outpatient Department of Hepatitis, The Sixth Affiliated People's Hospital of Dalian Medical University, Dalian, Liaoning, China.
  • Dan-Dan Li
    Department of Thoracic Surgery, No. 153 Hospital of Liberation Army, Zhengzhou, China.
  • Yan Liu
    Department of Clinical Microbiology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, People's Republic of China.
  • Yang Yang
    Department of Gastrointestinal Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, China.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals